Substituted 4-Carboxymethylpyroglutamic Acid Diamides as Potent and Selective Inhibitors of Fibroblast Activation Protein-Reference-Cited by-同舟云学术

Substituted 4-Carboxymethylpyroglutamic Acid Diamides as Potent and Selective Inhibitors of Fibroblast Activation Protein

Published:2010-08-18 Issue:18 Volume:53 Page:6572-6583
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Tsai Ting-Yueh¹,Yeh Teng-Kuang¹,Chen Xin¹,Hsu Tsu¹,Jao Yu-Chen¹,Huang Chih-Hsiang¹,Song Jen-Shin¹,Huang Yu-Chen¹,Chien Chia-Hui¹,Chiu Jing-Huai¹,Yen Shih-Chieh¹,Tang Hung-Kuan¹,Chao Yu-Sheng¹,Jiaang Weir-Torn¹

Affiliation:

1. Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, No. 35, Keyan Road, Zhunan Town, Miaoli Country 350, Taiwan, R.O.C

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm1002556

Reference43 articles.

1. The prolyl oligopeptidase family

2. Prolyl peptidases: a serine protease subfamily with high potential for drug discovery

3. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers.

4. Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells.

5. Structural and Kinetic Analysis of the Substrate Specificity of Human Fibroblast Activation Protein α

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Clinical Implications of FAPI;Clinical Nuclear Medicine;2024-07-18

2. Sensitive quantification of fibroblast activation protein and high-throughput screening for inhibition by FDA-approved compounds;2024-06-26

3. DBU‐Catalyzed Glutamation of Phenols, Thiophenols, Secondary Amines and Imides;European Journal of Organic Chemistry;2024-05-31

4. An Automated Radiosynthesis of [<sup>68</sup>Ga]Ga-FAPI-46 for Routine Clinical Use;Journal of Visualized Experiments;2024-05-24

5. Development, preclinical evaluation and preliminary dosimetry profiling of SB03178, a first-of-its-kind benzo[h]quinoline-based fibroblast activation protein-α-targeted radiotheranostic for cancer imaging and therapy;European Journal of Medicinal Chemistry;2024-03